BioSpace - Print News Article

GlaxoSmithKline (GSK) To Take $2.4 Billion Charge To Cover Avandia Cases, Other Legal Woes 7/26/2010 4:12:43 PM NPR -- Even for a flush drugmaker like GlaxoSmithKline, $2.4 billion dollars is a lot of money to wipe off the books in a single quarter.

GlaxoSmithKline (GSK) To Take $2.4 Billion Charge To Cover Avandia Cases, Other Legal Woes
7/26/2010 4:12:43 PM

NPR -- Even for a flush drugmaker like GlaxoSmithKline, $2.4 billion dollars is a lot of money to wipe off the books in a single quarter.